SCHEMBL9997284

SCHEMBL9997284

CC(=O)OC(C=Cc1cccc(C(C)C)c1)OC(C)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.42
MAPT P10636 4/20 0.42
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
HDAC4 P56524 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 2/20 0.42
HPGD P15428 2/20 0.42
ALOX15 P16050 2/20 0.42
ALOX12 P18054 2/20 0.42
MDM4 O15151 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
TYR P14679 1/20 0.42
CA5A P35218 1/20 0.42
MDM2 Q00987 1/20 0.42
CA9 Q16790 1/20 0.42
HDAC2 Q92769 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997461 0.81 LMNA (0.49) CYP3A4MAPTALDH1A1KDM4ESMN1; SMN2
SCHEMBL9997459 0.81 LMNA (0.49) CYP3A4MAPTALDH1A1KDM4ESMN1; SMN2
SCHEMBL9998024 0.81 KDM4E (0.54) CYP3A4MAPTALDH1A1KDM4ESMN1; SMN2
SCHEMBL9998207 0.80 HSD17B3 (0.54) MAPTALDH1A1HTTCYP2D6MEN1
SCHEMBL9997721 0.80 NFE2L2 (0.52)
SCHEMBL9997759 0.80 CYP1A2 (0.54) CYP3A4SMN1; SMN2HPGDCYP1A2CYP2D6
SCHEMBL9997717 0.80 NFE2L2 (0.52)
SCHEMBL9998209 0.80 HSD17B3 (0.54) MAPTALDH1A1HTTCYP2D6MEN1
SCHEMBL9997761 0.80 CYP1A2 (0.54) CYP3A4SMN1; SMN2HPGDCYP1A2CYP2D6
SCHEMBL7097856 0.79 TDP1 (0.52) CYP3A4MAPTALDH1A1HDAC4HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP3A4 36/4885MAPT 2206/4885ALDH1A1 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.